Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Abstract:

:In breast cancer (BC) patients, local recurrences often arise in proximity of the surgical scar, suggesting that response to surgery may have a causative role. Radiotherapy (RT) after lumpectomy significantly reduces the risk of recurrence. We investigated the direct effects of surgery and of RT delivered intraoperatively (IORT), by collecting irradiated and non-irradiated breast tissues from BC patients, after tumor removal. These breast tissue specimens have been profiled for their microRNA (miR) expression, in search of differentially expressed miR among patients treated or not with IORT. Our results demonstrate that IORT elicits effects that go beyond the direct killing of residual tumor cells. IORT altered the wound response, inducing the expression of miR-223 in the peri-tumoral breast tissue. miR-223 downregulated the local expression of epidermal growth factor (EGF), leading to decreased activation of EGF receptor (EGFR) on target cells and, eventually, dampening a positive EGF-EGFR autocrine/paracrine stimulation loop induced by the post-surgical wound-healing response. Accordingly, both RT-induced miR-223 and peri-operative inhibition of EGFR efficiently prevented BC cell growth and reduced recurrence formation in mouse models of BC. Our study uncovers unknown effects of RT delivered on a wounded tissue and prompts to the use of anti-EGFR treatments, in a peri-operative treatment schedule, aimed to timely treat BC patients and restrain recurrence formation.

journal_name

Oncogene

journal_title

Oncogene

authors

Fabris L,Berton S,Citron F,D'Andrea S,Segatto I,Nicoloso MS,Massarut S,Armenia J,Zafarana G,Rossi S,Ivan C,Perin T,Vaidya JS,Avanzo M,Roncadin M,Schiappacassi M,Bristow RG,Calin G,Baldassarre G,Belletti B

doi

10.1038/onc.2016.23

subject

Has Abstract

pub_date

2016-09-15 00:00:00

pages

4914-26

issue

37

eissn

0950-9232

issn

1476-5594

pii

onc201623

journal_volume

35

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).

    abstract::Epithelial-to-mesenchymal transition (EMT) causes fibrosis, cancer progression and metastasis. Integrin-linked kinase (ILK) is a focal adhesion adaptor and a serine/threonine protein kinase that regulates cell proliferation, survival and EMT. Elucidating the molecular mechanisms necessary for development and progressi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.30

    authors: Serrano I,McDonald PC,Lock FE,Dedhar S

    更新日期:2013-01-03 00:00:00

  • Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.

    abstract::xCT, the functional subunit of the cystine/glutamate transporter xc- system, plays a critical role in the maintenance of intracellular glutathione and redox balance. Disruption of xCT significantly inhibits the growth of a variety of carcinomas, including lymphoma, glioma, prostate and breast cancer. However, the role...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.414

    authors: Chen RS,Song YM,Zhou ZY,Tong T,Li Y,Fu M,Guo XL,Dong LJ,He X,Qiao HX,Zhan QM,Li W

    更新日期:2009-01-29 00:00:00

  • The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.

    abstract::The role of the hepatitis B virus protein HBx in liver cell proliferation and apoptosis remains controversial. Using a transgenic mouse model, we have recently shown that HBx stimulates the apoptotic turnover of hepatocytes, independently of p53. In this paper, we tested whether the proapoptotic function of HBx can in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205110

    authors: Terradillos O,de La Coste A,Pollicino T,Neuveut C,Sitterlin D,Lecoeur H,Gougeon ML,Kahn A,Buendia MA

    更新日期:2002-01-17 00:00:00

  • Mechanisms of the androgen receptor splicing in prostate cancer cells.

    abstract::Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most abundantly expressed variant that drives p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.284

    authors: Liu LL,Xie N,Sun S,Plymate S,Mostaghel E,Dong X

    更新日期:2014-06-12 00:00:00

  • The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.

    abstract::As a result of the synovial sarcoma-associated t(X;18) translocation, the SS18 gene on chromosome 18 is fused to either one of the three closely related SSX genes on the X chromosome. The SS18 protein is thought to act as a transcriptional co-activator, whereas the SSX proteins are thought to act as transcriptional co...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210688

    authors: de Bruijn DR,van Dijk AH,Willemse MP,van Kessel AG

    更新日期:2008-01-24 00:00:00

  • Dinucleotide repeats negatively modulate the promoter activity of Cyr61 and is unstable in hepatocellular carcinoma patients.

    abstract::Cyr61 is a secreted, cysteine-rich, heparin-binding protein that mediates diverse functions including extracellular matrix formation, differentiation, cell proliferation, adhesion, migration, survival, as well as angiogenesis and tumorigenesis. In this study, we found that Cyr61 gene expression is significantly downre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208550

    authors: Wang B,Ren J,Ooi LL,Chong SS,Lee CG

    更新日期:2005-06-02 00:00:00

  • Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

    abstract::The HER-2/neu proto-oncogene is homologous with, but distinct from, the epidermal growth factor receptor. Current evidence indicates that this gene is frequently amplified and/or overexpressed in some human breast and ovarian cancers and that these alterations may be clinically important; however, little is known abou...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Press MF,Cordon-Cardo C,Slamon DJ

    更新日期:1990-07-01 00:00:00

  • Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas that frequently arise in patients with neurofibromatosis type 1 (NF1). Most of these tumors are unresectable at diagnosis and minimally responsive to conventional treatment, lending urgency to the identification of new pathway dependencies and ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0965-5

    authors: Ki DH,Oppel F,Durbin AD,Look AT

    更新日期:2019-09-01 00:00:00

  • Modulation of Nr-13 antideath activity by peptide aptamers.

    abstract::Tumor cells are characterized by deregulated proliferation and resistance to proapoptotic stimuli. The Bcl-2 family of antiapoptotic proteins is overexpressed in a large number of chemoresistant tumors. Downregulation or inhibition of antiapoptotic proteins might result in the sensitization of cancer cells to chemothe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209832

    authors: Nouvion AL,Thibaut J,Lohez OD,Venet S,Colas P,Gillet G,Lalle P

    更新日期:2007-02-01 00:00:00

  • The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.

    abstract::The whey acidic protein (WAP) domain is a conserved motif, containing eight cysteines found in a characteristic 4-disulphide core arrangement, that is present in a number of otherwise unrelated proteins. WAP motifs are present in SLPI and elafin, two antiproteinases located on chromosome 20q12-13, in a locus rich in p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205363

    authors: Bingle L,Singleton V,Bingle CD

    更新日期:2002-04-18 00:00:00

  • The PR status of the originating cell of ER/PR-negative mouse mammary tumors.

    abstract::Progesterone receptor (PR) is usually co-localized with estrogen receptor (ER) in normal mammary cells. It is not known whether ER/PR-negative human breast cancer arises from an ER/PR-negative cell or from an ER/PR-positive cell that later lost ER/PR. Using intraductal injection of a lentivirus to deliver both an onco...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.465

    authors: Dong J,Zhao W,Shi A,Toneff M,Lydon J,So D,Li Y

    更新日期:2016-08-04 00:00:00

  • E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.

    abstract::The E2F1 transcription factor, which is deregulated in most human cancers by mutations in the p16-cyclin D-Rb pathway, has both oncogenic and tumor-suppressive properties. This is dramatically illustrated by the phenotype of an E2F1 transgenic mouse model that spontaneously develops tumors in the skin and other epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209120

    authors: Russell JL,Weaks RL,Berton TR,Johnson DG

    更新日期:2006-02-09 00:00:00

  • Dysregulation of growth factor signaling in human hepatocellular carcinoma.

    abstract::Dysregulation of pleiotropic growth factors, receptors and their downstream signaling pathway components represent a central protumorigenic principle in human hepatocarcinogenesis. Especially the Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/beta-catenin/FZD)...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209556

    authors: Breuhahn K,Longerich T,Schirmacher P

    更新日期:2006-06-26 00:00:00

  • COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.

    abstract::Biomarkers that predict disease progression might assist the development of better therapeutic strategies for aggressive cancers, such as ovarian cancer. Here, we investigated the role of collagen type XI alpha 1 (COL11A1) in cell invasiveness and tumor formation and the prognostic impact of COL11A1 expression in ovar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.307

    authors: Wu YH,Chang TH,Huang YF,Huang HD,Chou CY

    更新日期:2014-06-26 00:00:00

  • Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.

    abstract::The Cbl family proteins Cbl, Cbl-b, and Cbl-c/Cbl-3 are thought to regulate signaling through protein-tyrosine kinases, positively as scaffold proteins and negatively as ubiquitin ligases. However, the precise signaling pathways and target proteins for each Cbl family member are not well understood. Here we show that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207298

    authors: Kim M,Tezuka T,Tanaka K,Yamamoto T

    更新日期:2004-03-04 00:00:00

  • Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.

    abstract::Previously, we have mimicked human neurofibromatosis type 2 (NF2) in conditional Nf2 mutant (P0Cre;Nf2flox2/flox2) mice. Schwannomas, characteristic for NF2, were found at low frequency in older mice. Here, we report that these mice, upon additional hemizygosity for p53, rapidly develop multiple tumours showing featur...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207858

    authors: Robanus-Maandag E,Giovannini M,van der Valk M,Niwa-Kawakita M,Abramowski V,Antonescu C,Thomas G,Berns A

    更新日期:2004-08-26 00:00:00

  • Catch of the day: zebrafish as a human cancer model.

    abstract::Zebrafish are making big waves in the field of cancer research. The effect has been widespread and continues to gain speed as more and more cancer researchers ride the wave of zebrafish biology. This has been largely due to the development of transgenic and xenograft models of cancer, which recapitulate many aspects o...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.95

    authors: Stoletov K,Klemke R

    更新日期:2008-07-31 00:00:00

  • Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.

    abstract::Transformed cells express high levels of non-telomeric reverse-transcriptase (RT) activity of retrotransposon and endogenous retrovirus origin. We previously reported that RT inhibition, either pharmacological or through transient silencing of RT-encoding LINE-1 (L1) elements by RNA interference (RNAi), reduced prolif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210214

    authors: Oricchio E,Sciamanna I,Beraldi R,Tolstonog GV,Schumann GG,Spadafora C

    更新日期:2007-06-21 00:00:00

  • TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

    abstract::Tumor suppressor p53 has been shown to repress expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. The p63 gene, recently identified as a p53-relative, encodes multiple isoforms with structural and functional similarities and differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205330

    authors: Senoo M,Matsumura Y,Habu S

    更新日期:2002-04-11 00:00:00

  • Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.

    abstract::Rearrangements of the NFKB2 gene are associated with lymphoid malignancies, but the functional significance of these alterations is not known. Here we characterize structurally and functionally a rearranged NFKB2 gene identified at the T cell lymphoma line, HUT78. The rearrangement has truncated NFKB2 sequences within...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zhang J,Chang CC,Lombardi L,Dalla-Favera R

    更新日期:1994-07-01 00:00:00

  • Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.

    abstract::The MLL (HRX/ALL-1 gene is frequently disrupted in infantile leukemias and therapy-related leukemias and fused to various translocation partner genes. We previously showed that chimeric MLL proteins localize in the nuclei in a fashion similar to that of MLL protein even if the partner gene encodes a cytoplasmic protei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202400

    authors: Joh T,Hosokawa Y,Suzuki R,Takahashi T,Seto M

    更新日期:1999-01-28 00:00:00

  • Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets.

    abstract::Medulloblastoma (MB) results from aberrant development of cerebellar neurons in which altered hedgehog (Hh) signalling plays a major role. We investigated the possible influence of Hh signalling on ErbB-receptor expression in MB, in particular that of the ErbB-4 CYT-1 and CYT-2 isoforms generated by alternative splici...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209716

    authors: Ferretti E,Di Marcotullio L,Gessi M,Mattei T,Greco A,Po A,De Smaele E,Giangaspero F,Riccardi R,Di Rocco C,Pazzaglia S,Maroder M,Alimandi M,Screpanti I,Gulino A

    更新日期:2006-11-23 00:00:00

  • Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.

    abstract::Cancer therapy drugs, such as diamminedichloroplatinum (cisplatin), mitomycin C, etoposide and a number of other compounds, as well as energy-rich radiation, are known to act on cellular DNA. These agents are shown to induce nuclear accumulation of the so-called tumor-suppressor protein p53 in fibroblastoid cells, as ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fritsche M,Haessler C,Brandner G

    更新日期:1993-02-01 00:00:00

  • Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel phospholipase C-gamma regulated gene negatively associated with prostate tumor invasion.

    abstract::The most ominous development in tumor progression is the transition to an invasive and metastatic phenotype. Little is known, however, about the molecular alterations that cause a tumor to become invasive. In view of this, we have used microarray expression analysis to evaluate the expression profiles of a unique pane...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204379

    authors: Manos EJ,Kim ML,Kassis J,Chang PY,Wells A,Jones DA

    更新日期:2001-05-17 00:00:00

  • NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

    abstract::The recent years have seen a significant shift in the expectations for the therapeutic management of disseminated melanoma. The clinical success of BRAF targeted therapy suggests that long-term disease control may one day be a reality for genetically defined subgroups of melanoma patients. Despite this progress, few a...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.453

    authors: Fedorenko IV,Gibney GT,Smalley KS

    更新日期:2013-06-20 00:00:00

  • NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

    abstract::Melanoma dedifferentiation, characterized by the loss of MITF and MITF regulated genes and by upregulation of stemness markers as CD271, is implicated in resistance to chemotherapy, target therapy and immunotherapy. The identification of intrinsic mechanisms fostering melanoma dedifferentiation may provide actionable ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.355

    authors: Perotti V,Baldassari P,Molla A,Vegetti C,Bersani I,Maurichi A,Santinami M,Anichini A,Mortarini R

    更新日期:2016-06-02 00:00:00

  • Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.

    abstract::Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence of metastases. We and others demonstrated that nuclear ErbB-2 (NErbB-2) also plays a key role in BC and is a poor prognostic factor in ErbB...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.281

    authors: Venturutti L,Romero LV,Urtreger AJ,Chervo MF,Cordo Russo RI,Mercogliano MF,Inurrigarro G,Pereyra MG,Proietti CJ,Izzo F,Díaz Flaqué MC,Sundblad V,Roa JC,Guzmán P,Bal de Kier Joffé ED,Charreau EH,Schillaci R,Elizalde PV

    更新日期:2016-04-28 00:00:00

  • EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

    abstract::Amplification and rearrangements of the epidermal growth factor receptor (EGFR) gene are frequently found in glioblastoma multiforme (GBM). The most common variant is EGFR variant III (EGFRvIII). Research suggests that EGFRvIII could be a marker for a cancer stem cell or tumor-initiating population. If amplification a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.280

    authors: Del Vecchio CA,Giacomini CP,Vogel H,Jensen KC,Florio T,Merlo A,Pollack JR,Wong AJ

    更新日期:2013-05-23 00:00:00

  • Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

    abstract::While studying Bim, a BH3-only proapoptotic protein, we identified an approximately 36 kDa protein, which was abundantly expressed in all five strains of primary normal human prostate (NHP) epithelial cells but significantly reduced or lost in seven prostate cancer cell lines. The approximately 36 kDa protein was subs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206196

    authors: Liu JW,Shen JJ,Tanzillo-Swarts A,Bhatia B,Maldonado CM,Person MD,Lau SS,Tang DG

    更新日期:2003-03-13 00:00:00

  • p23rab2, a ras-like GTPase with a -GGGCC C-terminus, is isoprenylated but not detectably carboxymethylated in NIH3T3 cells.

    abstract::With the development of a specific anti-rab2 antiserum, p23rab2, a ras-like GTPase with a -GGGCC C-terminus, has been localized mainly to the particulate (P100) fraction in NIH3T3 cells, although a small amount of this protein also appears in the soluble fraction. The endogenous p23rab2 is isoprenylated in intact cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wei C,Lutz R,Sinensky M,Macara IG

    更新日期:1992-03-01 00:00:00